// App-Quantinova.ai

49 : Genomic/genetic testing patterns for patients with metastatic castrate-resistant prostate cancer: Results from a real-world study in the United States.

Researchers

Presenter

  • Andrea Leith

Principal Investigators

  • Amanda Ribbands

  • Matthew Last

  • Alicia Gayle

  • Sarah Payne

  • Charles McCrea

  • Lingfeng Yang

  • Joseph E. Burgents

  • Sameer Ghate

Medical Centers

  • Adelphi Real World, Bollington, United Kingdom

  • AstraZeneca UK Limited, Cambridge, DE, United Kingdom

  • Merck & Co., Inc., Kenilworth, NJ

  • Merck & Co., Inc., Kenilworth, NJ

Locations

  • United Kingdom

  • United States

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved